Catalyst Wire Dossier Catalyst Wire Dossier

Milsaperidone

Milsaperidone · Vanda Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Milsaperidone, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder [Phase 3]

See pricing